Every S-3 that ChronoScale Holdings Corporation (CHRN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-3 covers the shelf registration that lets an established company sell over time, so if you follow CHRN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CHRN filings page.
ChronoScale Holdings Corporation may offer securities under a shelf registration with an aggregate public offering price of up to $500,000,000, in one or more offerings. The securities may include non-convertible preferred stock, debt securities and junior subordinated debt securities. Selling securityholders may also offer securities in amounts set out in a prospectus supplement. Unless the applicable prospectus supplement or free writing prospectus provides otherwise, ChronoScale expects to use net proceeds from its own offerings for working capital and general corporate purposes.
ChronoScale provides cloud services through ChronoScale Corporation at third-party colocation centers. A two-year strategic partnership with Microsoft, entered into August 6, 2026, supports a planned deployment of approximately 50 megawatts of AI compute capacity, expected to be completed in the first calendar quarter of 2027. The deployment is subject to financing on favorable terms and other customary development, construction and operational conditions and milestones; penalties and other credits could be available to the counterparty if ChronoScale does not meet or perform them.
ChronoScale Holdings Corporation filed a pre-effective amendment to an S-3 registration covering the resale of 1,097,509 shares of common stock previously issued or issuable from private placements. These shares include common issued or issuable upon conversion of Series B preferred stock and exercise of investor and placement agent warrants.
The company will not receive proceeds from sales by the selling stockholders. ChronoScale now operates primarily a cloud business providing GPU-based infrastructure for AI and machine learning workloads, alongside its Legacy Ekso exoskeleton segment, which is classified as held for sale with divestiture targeted by the first fiscal quarter of 2027.
The filing also reflects ChronoScale Holdings’ status as successor issuer after a July 2026 Nevada holding company reorganization and describes significant risks, including large historical net losses, dependence on a single cloud customer expected to represent 99.5% of revenue for the year ended May 31, 2026, reliance on a few GPU suppliers, expected future capital needs and potential shareholder dilution.
ChronoScale Corporation is registering 1,097,509 shares of common stock for resale by selling stockholders pursuant to this prospectus. The resale covers shares issuable upon conversion and warrants from private placements, and the company will receive no proceeds from these resales.
The prospectus lists the sources of the Shares as: 15,389 2025 Placement Agent Warrant Shares; 711,922 Conversion Shares from Series B Preferred conversions; 355,960 Investor Warrant Shares; and 14,238 2026 Placement Agent Warrant Shares. The prospectus states there were 145,214,825 shares outstanding as of June 25, 2026.